We assign a fundamental rating of 6 out of 10 to BWAY. BWAY was compared to 186 industry peers in the Health Care Equipment & Supplies industry. While BWAY has a great health rating, its profitability is only average at the moment. BWAY is growing strongly while it also seems undervalued. This is an interesting combination These ratings would make BWAY suitable for value and growth investing!
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.53% | ||
| ROE | 8.92% | ||
| ROIC | 2.75% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.78% | ||
| PM (TTM) | 12.73% | ||
| GM | 74.92% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.08 | ||
| Debt/FCF | 0.37 | ||
| Altman-Z | 6.63 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.19 | ||
| Quick Ratio | 3.02 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.53 | ||
| Fwd PE | 16.18 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 24.57 | ||
| EV/EBITDA | 86.08 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
ChartMill assigns a fundamental rating of 6 / 10 to BWAY.
ChartMill assigns a valuation rating of 7 / 10 to BRAINSWAY LTD-ADR (BWAY). This can be considered as Undervalued.
BRAINSWAY LTD-ADR (BWAY) has a profitability rating of 5 / 10.
The Earnings per Share (EPS) of BRAINSWAY LTD-ADR (BWAY) is expected to grow by 68.53% in the next year.